CAH
CARDINAL HEALTH INC
NYSE · Healthcare · Medical - Distribution · US
$252.65
−0.55%Year over year
Reported trailing growth
- Revenue
- +14.2%
- EBITDA
- +12.0%
- EBIT
- +14.9%
- EPS
- +12.4%
- Free cash flow
- +144.6%
- Operating cash flow
- +115.9%
Forward estimates
Based on analyst estimates
- Revenue
- +5.9%
- EBITDA
- +54.2%
- EPS
- +77.8%
Three-year CAGR
- Revenue
- +3.9%
- EBITDA
- +21.0%
- EBIT
- +28.1%
- Net income
- +26.2%
- EPS
- +27.8%
- Free cash flow
- +11.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026